J. Stone

Cellular and Molecular Neuroscience · Proceedings of the National Academy of Sciences of the United States of America · 2010–2015

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Stone trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Oliver D. Howes
  2. Shitij Kapur

Papers from J. Stone's perspective

Ordered by how strongly the researchers J. Stone trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. (American Journal of Psychiatry)
  2. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. (The Lancet)
  3. Dysfunction of ventral striatal reward prediction in schizophrenia (NeuroImage)
  4. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. (Proceedings of the National Academy of Sciences of the United States of America)
  5. A Systematic Review of the Prevalence of Schizophrenia (PLoS Medicine)
  6. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons (Journal of Neuroscience)
  7. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
  8. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. (British Journal of Pharmacology)
  9. Psychiatric comorbidities and schizophrenia. (Schizophrenia bulletin)
  10. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. (The Lancet)

Their papers